Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy-Reference-Cited by-同舟云学术

Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy

Published:2020-08-20 Issue:10 Volume:99 Page:2367-2375
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Chiesa Silvia,Hohaus Stefan,Falcinelli Lorenzo,D’Alò Francesco,Martelli Massimo Fabrizio,Manfrida Stefania,Beghella Bartoli Francesco^ORCID,Colosimo Cesare,Valentini Vincenzo,Aristei Cynthia,Balducci Mario

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04220-1.pdf

Reference45 articles.

1. CBTRUS (2000) Statistical report: primary brain tumors in the United States, 1992–1997. Central Brain Tumor Registry of the United States, Chicago

2. Milgrom S, Yahalom J (2015) The role of radiation therapy in the management of primary central nervous system. Leuk Lymph 56:1197–1204

3. Reni M, Ferreri AJM, Garancini MP, Villa E (1997) Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8:227–234

4. Nelson DF, Martz KL, Bonner H (1992) Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23:9–17

5. Vitolo U, Seymour F, Martelli M et al (2016) Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v91–v102

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma;Hematology;2023-08-07

2. Recent advances and challenges in primary central nervous system lymphoma: a narrative review;Translational Cancer Research;2023-05

3. Specific KIR-HLA genotypes predict the outcomes of refractory or recurrent primary central nervous system lymphoma;2022-10-11

4. Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma;Neuro-Oncology Practice;2022-06-22

5. Diagnostic accuracy of arterial spin labeling in differentiating between primary central nervous system lymphoma and high-grade glioma: a systematic review and meta-analysis;Expert Review of Anticancer Therapy;2022-05-31